[Neonatal hypoxic ischemic encephalopathy treated with acupuncture combined with acupoint injection: a randomized controlled trial]
- PMID: 26521569
[Neonatal hypoxic ischemic encephalopathy treated with acupuncture combined with acupoint injection: a randomized controlled trial]
Abstract
Objective: To observe the clinical efficacy difference in the treatment of neonatal hypoxic ischemic encephalopathy (NHIE) between the combined therapy of acupuncture land acupoint injection of nerve growth fac-tor (NGF) and the combined therapy of the intravenous drop of citicoline sodium and intramuscular injection of NGF.
Methods: Sixty-one cases of NHIE were randomized into an observation group (32 cases) and a control group (29 cases). In the observation group, acupuncture combined with acupint injection of NGF was adopted. The acupoints were Baihui (GV 20), Dazhui (GV 14) and Fengfu (GV 16), 0. 5 mL each acupoint, once a day. In the control group, the intravenous drop of citicoline sodium and intramuscular injection of NGF were used. The, treatment of 7 days made one session and 3 sessions were required. Separately, in 7, 14 and 21 days of treatment, the clinical efficacy, behavior nerve determination score and adverse reaction were observed in the two groups.
Results: In 7, 14 and 21 days of treatment, the total effective rates were 50. 0% (16/32), 68. 8% (22/32) and 78. 1% (25/32) in the observation group and were 69. 0% (20/29), 72. 4% (21/29) and 82. 8% (24/29) in the control group. The result in the control group was better than that in the observation group in the 7 days (P< 0. 05). The behavior determination scores in 7, 14 and 21 days were all improved obviously as compared with those before treatment in the two groups (P<0. 05, P<0. 01). The score in the control group was better than that in the, observation group in the 7 days (P<0. 05). The differences were not significant in the scores between the two groups in 14 and 21 days (both P>0. 05). The incidence of adverse reaction in the observation group was lower than that in, the control group [14. 3% (5/35) vs 31. 4% (11/35), P<0. 05] and the severity was mild.
Conclusion: In the treatment of NHIE with the combined therapy of acupuncture and acupint injection, the overall efficacy in 1 week; is inferior to that of the combined therapy of the intravenous drop of citicoline sodium and intramuscular injection of NGF. But the efficacy is improved gradually along with the treatment progression and the adverse reaction is less.
Similar articles
-
[Vegetative state treated with acupoint injection combined with plum-blossom needle in children: a randomized controlled trial].Zhongguo Zhen Jiu. 2014 May;34(5):421-5. Zhongguo Zhen Jiu. 2014. PMID: 25022107 Clinical Trial. Chinese.
-
[Allergic rhinitis treated with acupuncture and the triple-strong stimulation therapy at dazhui (GV 14): a randomized controlled trial].Zhongguo Zhen Jiu. 2014 Feb;34(2):110-4. Zhongguo Zhen Jiu. 2014. PMID: 24796042 Clinical Trial. Chinese.
-
[Effect of injecting mouse nerve growth factor in different ways on motor development, cerebral hemodynamics and biochemical metabolism in children with cerebral palsy].Zhongguo Zhen Jiu. 2020 Aug 12;40(8):839-44. doi: 10.13703/j.0255-2930.20190525-0003. Zhongguo Zhen Jiu. 2020. PMID: 32869592 Clinical Trial. Chinese.
-
["Governor vessel daoqi method of acupuncture" combined with estazolam for insomnia: a randomized controlled trial].Zhongguo Zhen Jiu. 2018 May 12;38(5):4633-7. doi: 10.13703/j.0255-2930.2018.05.003. Zhongguo Zhen Jiu. 2018. PMID: 29797908 Review. Chinese.
-
Acupuncture points for treating Parkinson's disease based on animal studies.Chin J Integr Med. 2016 Oct;22(10):723-7. doi: 10.1007/s11655-016-2525-y. Epub 2016 Jul 26. Chin J Integr Med. 2016. PMID: 27460492 Review.
Cited by
-
GM1 Acupoint Injection Improves Mental Retardation in Children with Cerebral Palsy.J Mol Neurosci. 2019 Feb;67(2):305-311. doi: 10.1007/s12031-018-1239-3. Epub 2019 Jan 2. J Mol Neurosci. 2019. PMID: 30604381 Clinical Trial.
-
Acupuncture for hypoxic ischemic encephalopathy in neonates.Cochrane Database Syst Rev. 2024 Dec 18;12(12):CD007968. doi: 10.1002/14651858.CD007968.pub3. Cochrane Database Syst Rev. 2024. PMID: 39692246
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical